Denosumab Biosimilar Injection in Post Menopausal Women With Osteoporosis

NCT05419427 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

552

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoporosis, Postmenopausal

Interventions

DRUG: Denosumab
DRUG: Denosumab-Ref

Sponsor

Lambda Therapeutic Research Ltd.

Collaborators

[object Object]